ALX Oncology
ALXO
ALXO
61 hedge funds and large institutions have $12.6M invested in ALX Oncology in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 32 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less capital invested
Capital invested by funds: $22.1M → $12.6M (-$9.55M)
71% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 34
72% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 32
Holders
61
Holding in Top 10
1
Calls
$48K
Puts
$7K
Top Buyers
1 | +$492K | |
2 | +$84.4K | |
3 | +$34K | |
4 |
Renaissance Technologies
New York
|
+$29.5K |
5 |
Squarepoint
New York
|
+$24.2K |
Top Sellers
1 | -$663K | |
2 | -$343K | |
3 | -$255K | |
4 |
State Street
Boston,
Massachusetts
|
-$247K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
-$189K |